Loading chat...
OK HB1416
Bill
Status
3/4/2025
Primary Sponsor
Josh West
Click for details
AI Summary
-
Creates new Section 1313.1 of Title 74 of the Oklahoma Statutes establishing requirements for state employee group insurance plans' preferred drug lists (PDLs).
-
Requires insurers to ensure FDA-approved non-opioid pain treatment drugs are not disadvantaged or discouraged in PDL coverage relative to opioid or narcotic drugs for pain management.
-
Permits insurers to prefer certain opioid medications over other opioids or certain non-opioid medications over other non-opioids within their PDLs.
-
Applies requirements to non-opioid treatments that have been reviewed and approved for coverage by group insurance plans and to drugs provided through pharmacy benefits manager contracts.
-
Becomes effective November 1, 2025.
Legislative Description
Non-opioid treatment; terms; preferred drug lists; discretion; drug treatment; United States Food and Drug Administration; coverage; non-opioid drugs; reimbursement; effective date.
Last Action
Second Reading referred to Health and Human Services Committee then to Appropriations Committee
4/1/2025